| Transcriptional plasticity promotes primary and acquired resistance to BET inhibition P Rathert, M Roth, T Neumann, F Muerdter, JS Roe, M Muhar, S Deswal, ... Nature 525 (7570), 543-547, 2015 | 491 | 2015 |
| BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1 SJ Hogg, SJ Vervoort, S Deswal, CJ Ott, J Li, LA Cluse, PA Beavis, ... Cell reports 18 (9), 2162-2174, 2017 | 271 | 2017 |
| Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy I Uribesalgo, D Hoffmann, Y Zhang, A Kavirayani, J Lazovic, J Berta, ... EMBO molecular medicine 11 (8), e9266, 2019 | 92 | 2019 |
| AKIRIN2 controls the nuclear import of proteasomes in vertebrates M de Almeida, M Hinterndorfer, H Brunner, I Grishkovskaya, K Singh, ... Nature 599 (7885), 491-496, 2021 | 61 | 2021 |
| SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer Genes and Development 30, 2187-2198, 2016 | 60 | 2016 |
| Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors S Deswal, N Roy European journal of medicinal chemistry 41 (11), 1339-1346, 2006 | 52 | 2006 |
| Kidins220/ARMS associates with B-Raf and the TCR, promoting sustained Erk signaling in T cells S Deswal, A Meyer, GJ Fiala, AE Eisenhardt, LC Schmitt, M Salek, ... The Journal of Immunology 190 (5), 1927-1935, 2013 | 36 | 2013 |
| Pre-clustered TCR complexes E Molnár, S Deswal, WWA Schamel FEBS letters 584 (24), 4832-4837, 2010 | 29 | 2010 |
| A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors S Deswal, N Roy European journal of medicinal chemistry 42 (4), 463-470, 2007 | 24 | 2007 |
| Quantitative analysis of protein phosphorylations and interactions by multi-colour IP-FCM as an input for kinetic modelling of signalling networks S Deswal, AK Schulze, T Höfer, WWA Schamel PloS one 6 (7), e22928, 2011 | 20 | 2011 |
| Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists S Deswal, N Roy European journal of medicinal chemistry 41 (4), 552-557, 2006 | 18 | 2006 |
| Detection of phosphorylated T and B cell antigen receptor species by Phos-tag SDS-and Blue Native-PAGE S Deswal, K Beck-García, B Blumenthal, EP Dopfer, WWA Schamel Immunology letters 130 (1-2), 51-56, 2010 | 17 | 2010 |
| Calorie restriction up-regulates iron and copper transport genes in Saccharomyces cerevisiae PK Sharma, N Mittal, S Deswal, N Roy Molecular BioSystems 7 (2), 394-402, 2011 | 16 | 2011 |
| Semi-automatic determination of cell surface areas used in systems biology V Morath, M Keuper, M Rodriguez-Franco, S Deswal, G Fiala, ... Front Biosci (Elite Ed) 5, 533-45, 2013 | 12 | 2013 |
| Models of antigen receptor activation in the design of vaccines E Molnár, EP Dopfer, S Deswal, WWA Schamel Current pharmaceutical design 15 (28), 3237-3248, 2009 | 10 | 2009 |
| Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors' European Journal of Medicinal Chemistry vol. 41, 2006 S Deswal XP024993923, 1339-1346, 0 | 7 | |
| Data types and resources SK Ashenden, S Deswal, KC Bulusu, A Bartosik, K Shameer The Era of Artificial Intelligence, Machine Learning, and Data Science in …, 2021 | 4 | 2021 |
| CD3ζ S Deswal, WWA Schamel Springer Science+ Business Media, 2012 | 3 | 2012 |
| CD3 S Deswal, WWA Schamel Springer Science+ Business Media, 2012 | 1 | 2012 |
| Pooled CRISPR KO Screens for Target Identification A Grotz, S Deswal Genome Editing in Drug Discovery, 113-125, 2022 | | 2022 |
Johannes ZuberGroup Leader - IMP (Research Institute of Molecular Pathology), Vienna, AustriaVerified email at imp.ac.at
